Sean Parker’s cancer institute may have found a blood test to determine if patients will respond treatment

 Scientists in collaboration with tech billionaire Sean Parker’s Institute for Cancer Immunotherapy may have found a way to predict whether melanoma patients will respond to treatments that target the PD-1 (programmed cell death protein) pathway in tumors through a simple blood test, according to a paper in the scientific journal Nature. The former Facebook president launched the… Read More

from https://techcrunch.com/2017/04/10/sean-parkers-cancer-institute-may-have-found-a-blood-test-to-determine-if-patients-will-respond-treatment/?ncid=rss